Wells Fargo’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Buy |
61,106
+1,459
| +2% | +$25.5K | ﹤0.01% | 3320 |
|
|
2025
Q1 | $750K | Buy |
59,647
+17,946
| +43% | +$226K | ﹤0.01% | 3439 |
|
|
2024
Q4 | $440K | Buy |
41,701
+13,361
| +47% | +$141K | ﹤0.01% | 3798 |
|
|
2024
Q3 | $411K | Buy |
28,340
+12,584
| +80% | +$182K | ﹤0.01% | 3752 |
|
|
2024
Q2 | $134K | Buy |
15,756
+7,168
| +83% | +$61K | ﹤0.01% | 4414 |
|
|
2024
Q1 | $87.8K | Buy |
8,588
+1,090
| +15% | +$11.1K | ﹤0.01% | 4593 |
|
|
2023
Q4 | $41.1K | Buy |
7,498
+1,562
| +26% | +$8.56K | ﹤0.01% | 4924 |
|
|
2023
Q3 | $22.4K | Sell |
5,936
-3,574
| -38% | -$13.5K | ﹤0.01% | 5187 |
|
|
2023
Q2 | $63.7K | Buy |
9,510
+9,266
| +3,798% | +$62.1K | ﹤0.01% | 5027 |
|
|
2023
Q1 | $1.59K | Buy |
244
+8
| +3% | +$52 | ﹤0.01% | 5943 |
|
|
2022
Q4 | $2.01K | Buy |
236
+84
| +55% | +$716 | ﹤0.01% | 5686 |
|
|
2022
Q3 | $1K | Buy |
152
+4
| +3% | +$26 | ﹤0.01% | 6128 |
|
|
2022
Q2 | $1K | Sell |
148
-4,045
| -96% | -$27.3K | ﹤0.01% | 6296 |
|
|
2022
Q1 | $14K | Sell |
4,193
-4,339
| -51% | -$14.5K | ﹤0.01% | 5806 |
|
|
2021
Q4 | $57K | Sell |
8,532
-8,379
| -50% | -$56K | ﹤0.01% | 5466 |
|
|
2021
Q3 | $169K | Buy |
16,911
+16,323
| +2,776% | +$163K | ﹤0.01% | 4888 |
|
|
2021
Q2 | $18K | Sell |
588
-3,794
| -87% | -$116K | ﹤0.01% | 5615 |
|
|
2021
Q1 | $191K | Buy |
+4,382
| New | +$191K | ﹤0.01% | 4858 |
|